Skip to main content

AlphaCentric Advisors LLC

SEC CIK
0001913464
Latest filing
Jul 24, 2026

NRIX holding history

Nurix Therapeutics, Inc. in every 13F filed by AlphaCentric Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NRIX overviewAll 13F holders of NRIXFull Q2 2026 holdings

Shares (Q2 2026)
25,845
Value
$627.0K
% of portfolio
0.5%
Quarters held
3
Since Q4 2025
Holdings of NRIX by AlphaCentric Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202625,845$627.0K0.5%+274+1.1%AddedHolders
Q1 202625,571$396.4K0.4%+7,437+41.0%AddedHolders
Q4 202518,134$344.0K0.3%–No prior filingHolders